MDMA is on the brink of becoming accepted as a legal medication in therapy. What will be its applications, its legal status, and what did its journey look like?
Over the past decade, the phenomenon of ‘microdosing’ has had […]
By Olivier Taymans Matthew Johnson is associate director of the […]
By Thijs Roes When MAPS founder Rick Doblin was in […]
Society has a radical influence on the psychedelic experience itself, Ido Hartogsohn says.
The future of psychedelic science is not free of challenges. Here are the next big steps in psychedelic research.
By Olivier Taymans Alicia Danforth, PhD, is a licensed clinical […]